Despite cannabis stocks being major buzzkills this year, three companies have bucked the downtrend in a big way.
News & Analysis: Valens GroWorks
The Food and Drug Administration's consumer update on cannabidiol might appear damning, but investors can still profit from CBD's growth.
These cannabis pure-plays all gained at least 10% in an otherwise awful month for pot stocks.
Extraction-service providers appeared safe from near-term marijuana growing pains, but this isn't the case any longer.
While most marijuana stocks have gone up in smoke, this trio of cannabis stocks has shined this earnings season.
Marijuana stocks don't get much cheaper than this.
Cannabis stocks are down, but they're probably not out.
Fair-value adjustments and one-time benefits aren't needed for these companies to deliver the green.
Whereas most pot stocks are losing money, this niche industry became profitable almost from the get-go.
Yes, it is possible to minimize your investing risk while having exposure to the fast-growing cannabis industry.